| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.19B | 15.03B | 11.02B | 8.34B | 9.57B | 6.75B |
| Gross Profit | 6.36B | 5.28B | 4.97B | 4.80B | 6.70B | 4.27B |
| EBITDA | 5.42B | 7.16B | 7.64B | 6.17B | 7.23B | 4.37B |
| Net Income | 403.00M | 1.66B | 3.34B | 3.14B | 4.39B | 2.18B |
Balance Sheet | ||||||
| Total Assets | 70.08B | 71.06B | 67.29B | 29.00B | 26.21B | 22.90B |
| Cash, Cash Equivalents and Short-Term Investments | 176.00M | 106.00M | 161.00M | 582.00M | 157.00M | 654.00M |
| Total Debt | 13.90B | 14.49B | 12.43B | 6.80B | 6.38B | 6.77B |
| Total Liabilities | 27.44B | 28.09B | 27.43B | 11.57B | 10.52B | 9.65B |
| Stockholders Equity | 36.47B | 36.97B | 37.74B | 16.63B | 15.01B | 12.09B |
Cash Flow | ||||||
| Free Cash Flow | 1.59B | 5.24B | -5.37B | 1.21B | 2.71B | 1.67B |
| Operating Cash Flow | 8.23B | 8.76B | 6.41B | 5.92B | 6.33B | 3.94B |
| Investing Cash Flow | -6.81B | -7.81B | -11.22B | -3.32B | -3.33B | -1.54B |
| Financing Cash Flow | -3.28B | -1.01B | 4.39B | -2.18B | -3.50B | -1.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | $75.44B | 9.71 | 18.28% | 3.79% | 0.31% | -5.71% | |
73 Outperform | $36.17B | 6.40 | 14.34% | 1.17% | 50.77% | 800.70% | |
70 Outperform | $57.48B | 97.11 | 1.06% | 2.70% | 18.09% | -94.57% | |
69 Neutral | $55.87B | 65.10 | 14.78% | 2.64% | 1.96% | -18.06% | |
69 Neutral | $58.55B | 4.74 | 12.82% | 2.39% | -15.17% | -66.00% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |